JP2010540422A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540422A5
JP2010540422A5 JP2010525422A JP2010525422A JP2010540422A5 JP 2010540422 A5 JP2010540422 A5 JP 2010540422A5 JP 2010525422 A JP2010525422 A JP 2010525422A JP 2010525422 A JP2010525422 A JP 2010525422A JP 2010540422 A5 JP2010540422 A5 JP 2010540422A5
Authority
JP
Japan
Prior art keywords
optionally substituted
compound according
alkyl
hydrogen
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010525422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540422A (ja
Filing date
Publication date
Priority claimed from GB0718434A external-priority patent/GB0718434D0/en
Application filed filed Critical
Publication of JP2010540422A publication Critical patent/JP2010540422A/ja
Publication of JP2010540422A5 publication Critical patent/JP2010540422A5/ja
Pending legal-status Critical Current

Links

JP2010525422A 2007-09-21 2008-09-19 チエノピリミジン化合物類 Pending JP2010540422A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0718434A GB0718434D0 (en) 2007-09-21 2007-09-21 New chemical compounds
PCT/GB2008/003173 WO2009037463A1 (en) 2007-09-21 2008-09-19 Thienopyrimidine compounds

Publications (2)

Publication Number Publication Date
JP2010540422A JP2010540422A (ja) 2010-12-24
JP2010540422A5 true JP2010540422A5 (cg-RX-API-DMAC7.html) 2011-11-04

Family

ID=38670289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010525422A Pending JP2010540422A (ja) 2007-09-21 2008-09-19 チエノピリミジン化合物類

Country Status (5)

Country Link
US (5) US9120807B2 (cg-RX-API-DMAC7.html)
EP (1) EP2205607A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010540422A (cg-RX-API-DMAC7.html)
GB (1) GB0718434D0 (cg-RX-API-DMAC7.html)
WO (1) WO2009037463A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US10793636B2 (en) 2016-07-11 2020-10-06 Corvus Pharmaceuticals, Inc. Anti-CD73 antibodies
AU2018325451A1 (en) 2017-08-31 2020-03-05 Corvus Pharmaceuticals, Inc. Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
WO2023201267A1 (en) 2022-04-13 2023-10-19 Gilead Sciences, Inc. Combination therapy for treating trop-2 expressing cancers
US20250230168A1 (en) 2023-12-22 2025-07-17 Gilead Sciences, Inc. Azaspiro wrn inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
GB9915437D0 (en) * 1999-07-01 1999-09-01 Cerebrus Ltd Chemical compounds III
EA012926B1 (ru) * 2001-12-20 2010-02-26 Оси Фармасьютикалз, Инк. Пирролопиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение
NZ528591A (en) 2002-02-01 2006-11-30 King Pharmaceuticals Res & Dev 8-heteroaryl xanthine adenosine A2B receptor antagonists and their pharmaceutical use
US7449473B2 (en) * 2003-10-31 2008-11-11 Cv Therapeutics, Inc. Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonists
EP1989210A2 (en) * 2006-03-02 2008-11-12 Cv Therapeutics, Inc. A2a adenosine receptor antagonists

Similar Documents

Publication Publication Date Title
JP2013537203A5 (cg-RX-API-DMAC7.html)
JP2012512907A5 (cg-RX-API-DMAC7.html)
JP2010540424A5 (cg-RX-API-DMAC7.html)
JP2012528166A5 (cg-RX-API-DMAC7.html)
JP2009535358A5 (cg-RX-API-DMAC7.html)
JP2012255026A5 (cg-RX-API-DMAC7.html)
JP2013507439A5 (cg-RX-API-DMAC7.html)
JP2012533546A5 (cg-RX-API-DMAC7.html)
JP2014508804A5 (cg-RX-API-DMAC7.html)
JP2019526596A5 (cg-RX-API-DMAC7.html)
JP2013507425A5 (cg-RX-API-DMAC7.html)
JP2009530345A5 (cg-RX-API-DMAC7.html)
JP2009502743A5 (cg-RX-API-DMAC7.html)
JP2013507423A5 (cg-RX-API-DMAC7.html)
JP2009533410A5 (cg-RX-API-DMAC7.html)
JP2013510120A5 (cg-RX-API-DMAC7.html)
JP2013528180A5 (cg-RX-API-DMAC7.html)
JP2009531376A5 (cg-RX-API-DMAC7.html)
JP2010511721A5 (cg-RX-API-DMAC7.html)
JP2013537198A5 (cg-RX-API-DMAC7.html)
JP2013509429A5 (cg-RX-API-DMAC7.html)
JP2012522056A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
JP2011513410A5 (cg-RX-API-DMAC7.html)
JP2012512863A5 (cg-RX-API-DMAC7.html)